摘要
乳腺癌是全球女性中最常见的恶性肿瘤,是仅次于肺癌的第二大癌症导致的死亡。正如在其他恶性肿瘤中一样,非整倍性是乳腺癌的一个共性并影响其行为。非整倍性与纺锤体装配检查点 (SAC) 的不适当活动有关,SAC是在正常细胞中到达到中期染色体正确定位可防止后期发病的一个监控机制。有趣的是,广泛使用的抗微管药物、长春花碱和紫杉醇,通过作为慢性SAC活化的结果在有丝分裂中慢性阻滞来杀死癌细胞。解除对SAC的管制已在许多关于乳腺癌的报道中被报道,提出了一个有吸引力的治疗策略。我们在此综述了有关SAC缺点的现有知识和乳腺癌潜在分子机制,探讨了SAC作为乳腺癌治疗靶标的潜能。
关键词: 非整倍性,抗有丝分裂,乳腺癌,基因表达,纺锤体装配检查点,靶向治疗。
图形摘要
Current Cancer Drug Targets
Title:Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment
Volume: 15 Issue: 4
Author(s): Sandra Marques, Joana Fonseca, Patricia M.A. Silva and Hassan Bousbaa
Affiliation:
关键词: 非整倍性,抗有丝分裂,乳腺癌,基因表达,纺锤体装配检查点,靶向治疗。
摘要: Breast cancer is the most common malignancy in women worldwide and the second leading cause of cancer deaths after lung cancer. As in other malignancies, aneuploidy is a common feature of breast cancer and influences its behavior. Aneuploidy has been linked to inappropriate activity of the spindle assembly checkpoint (SAC), a surveillance mechanism that, in normal cells, prevents anaphase onset until correct alignment of all chromosomes at the metaphase is achieved. Interestingly, the widely used anti-microtubule drugs, vinca alkaloids and taxanes, kill cancer cells through chronic arrest in mitosis as a consequence of chronic SAC activation. Deregulated SAC has been reported in breast cancer in many reports and presents an attractive therapeutic strategy. We present here a review of the current knowledge on the SAC defects and the underlying molecular mechanisms in breast cancer, and discuss the potential of SAC components as targets for breast cancer therapies.
Export Options
About this article
Cite this article as:
Sandra Marques, Joana Fonseca, Patricia M.A. Silva and Hassan Bousbaa , Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment, Current Cancer Drug Targets 2015; 15 (4) . https://dx.doi.org/10.2174/1568009615666150302130010
DOI https://dx.doi.org/10.2174/1568009615666150302130010 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib
Current Drug Delivery Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours
Anti-Cancer Agents in Medicinal Chemistry Targeting Calcium Channels to Block Tumor Vascularization
Recent Patents on Anti-Cancer Drug Discovery Anti-carcinogenic Effect of Cathepsin K Inhibitor, Odanacatib with a Low Dose of Cisplatin Against Human Breast Carcinoma MCF-7 and MDA-MB231 Cells
Current Cancer Therapy Reviews Novel Approaches for Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Recent Advances in Psoriasis Therapy: Trends and Future Prospects
Current Drug Targets Metabolism of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy: A Review of the Literature
Current Drug Metabolism Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design Recent Advances in the Development of Immunoadhesins for Immune Therapy and as Anti-Infective Agents
Recent Patents on Anti-Infective Drug Discovery 1,5-Diaryl-3-oxo-1,4-pentadienes: A Case for Antineoplastics with Multiple Targets
Current Medicinal Chemistry Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development
Current Cancer Drug Targets Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Synergistic Effect of the Combination of Novel Suberoylanilide Hydroxamic Acid Derivatives with Cisplatin on Anti-proliferation of Human Cancer Cells
Medicinal Chemistry The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry Calcium Metabolism & Hypercalcemia in Adults
Current Medicinal Chemistry Promising Anticancer Drug Candidates Based on the 7-methoxychromone Scaffold: Synthesis and Evaluation of Antiproliferative Activity
Letters in Drug Design & Discovery Stem Cells as In Vitro Models of Disease
Current Stem Cell Research & Therapy Design, Synthesis and Docking study of Novel Imidazolyl Pyrazolopyridine Derivatives as Antitumor Agents Targeting MCF7 Cell Line
Current Organic Synthesis